Sun Pharma Advanced Research Company informs about press release

03 Feb 2026 Evaluate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharma Advanced Research Company has enclosed the Press Release about ‘Receipt of Priority Review Voucher associated with Sezaby Approval’, which they shall be released after this intimation.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Adv. Res Share Price

138.00 -2.00 (-1.43%)
06-Feb-2026 14:31 View Price Chart
Peers
Company Name CMP
Syngene Internation. 444.25
Indegene 486.90
CMS Info Systems 324.75
Sagility 48.22
Smartworks Coworking 457.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×